CC
EW icon

Centiva Capital’s Edwards Lifesciences EW Stock Holding History

Centiva Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825K Buy
+9,122
New +$764K 0.01% 706
2025
Q3 		– Sell
-18,515
Closed -$1.45M – 1318
2025
Q2 		$1.45M Buy
18,515
+8,352
+82% +$623K 0.02% 458
2025
Q1 		$737K Buy
10,163
+1,053
+12% +$75.4K 0.02% 614
2024
Q4 		$674K Buy
9,110
+4,641
+104% +$325K 0.01% 667
2024
Q3 		$295K Buy
+4,469
New +$325K 0.01% 1590
2024
Q2 		– Sell
-19,607
Closed -$1.87M – 2184
2024
Q1 		$1.87M Buy
19,607
+12,672
+183% +$1.06M 0.05% 371
2023
Q4 		$529K Sell
6,935
-16,118
-70% -$1.12M 0.01% 935
2023
Q3 		$1.6M Buy
23,053
+3,961
+21% +$318K 0.04% 460
2023
Q2 		$1.8M Buy
+19,092
New +$1.66M 0.04% 414
2022
Q4 		– Sell
-3,171
Closed -$262K – 1440
2022
Q3 		$262K Buy
+3,171
New +$305K ﹤0.01% 1094
2021
Q3 		– Sell
-3,988
Closed -$413K – 1372
2021
Q2 		$413K Buy
+3,988
New +$376K 0.01% 900
2020
Q4 		– Sell
-10,559
Closed -$843K – 960
2020
Q3 		$843K Sell
10,559
-4,040
-28% -$315K 0.06% 230
2020
Q2 		$1.01M Buy
+14,599
New +$1.04M 0.06% 174
2020
Q1 		– Sell
-9,462
Closed -$736K – 707
2019
Q4 		$736K Buy
+9,462
New +$739K 0.04% 341
2019
Q3 		– Sell
-1,662
Closed -$117K – 643
2019
Q2 		$102K Buy
+1,662
New +$100K 0.01% 367

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Centiva Capital's EW Position: Q2 2026 in Review

Centiva Capital opened a new position in Edwards Lifesciences (EW) in Q2 2026: 9,122 shares worth $825K. The stake represents 0.01% of the portfolio and ranks #706 among its holdings. This is a return to the name: Centiva Capital previously reported a position in EW as recently as Q2 2025.

Centiva Capital first reported a position in EW in Q2 2019 and has held it in 15 quarters since. The position peaked at $1.87M in Q1 2024. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Centiva Capital held 9,122 shares of Edwards Lifesciences worth $825K as of Q2 2026.
  • Edwards Lifesciences was a new Centiva Capital position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #706 holding.
  • Centiva Capital first reported a position in Edwards Lifesciences in Q2 2019 and has held it in 15 quarters since.
  • Centiva Capital's Edwards Lifesciences position peaked at $1.87M in Q1 2024.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.